With the implementation of ZAP70 gene missense mutation (rs104893674 (C > A)) analysis in the clinical setting, a more molecularly guided precision diagnosis approach could improve the prediction accuracy for likelihood of MPAL developing. This evidence concerns the gene ZAP70 and mixed phenotype acute leukemia.